Results 91 to 100 of about 44,168 (180)

Impact of Frontline Treatment Strategies on Outcomes in Patients With Acute Myeloid Leukemia, Myelodysplasia-Related. [PDF]

Cancer Rep (Hoboken)
Li Y, Jin D, Fang P, Meng X, He D, Lin J, Le J, Shu W, Yang Q, He J, Cai Z.   +10 more
europepmc   +1 more source

Ven a Venezuela

, 2006
ESP
openaire   +1 more source

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia. [PDF]

Hematol Oncol
Medawar G, Anoma JS, Hill E, Tharakan S, Sastow DL, Lok V, Hahn SB, Chen S, Kehoe T, Ramasamy C, Guetta-Weiss J, Meleveedu K, Lin C, Swoboda DM, Tremblay D, Coltoff A.   +15 more
europepmc   +1 more source

Joan Larzac, L’an que ven d’onte ven : escriure e renaisse sensa relambi

Revue des Langues Romanes, 2023
Sylvan Chabaud
doaj   +1 more source

Venetoclax retreatment in chronic lymphocytic leukemia is biologically rational and clinically effective. [PDF]

Blood Adv
Castonguay M, Anderson MA, Thompson P, Seymour JF.   +3 more
europepmc   +1 more source

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy. [PDF]

Cancer
Marvin-Peek J, DiNardo CD, Loghavi S, Ravandi F, Borthakur G, Daver NG, Kadia TM, Jabbour E, Dunbar A, Tang G, Short NJ, Haddad FG, Abbas HA, Kugler E, Maiti A, Issa GC, Takahashi K, Bhalla K, Pemmaraju N, Alvarado Y, Shpall EJ, Popat U, Ramdial J, Champlin RE, Kantarjian HM, Garcia-Manero G, Senapati J.   +26 more
europepmc   +1 more source

Infection by Different Clades of Candidozyma auris in a Galleria mellonella Model: Determining Virulence Levels. [PDF]

Mycopathologia
Marena GD, Lopez A, Carvalho GC, Pemán J, Perez-Royo JM, Garcia-Bustos V, González Á, Brell PM, Ruiz MDP, Macian LZ, Saez CV, Mansilla AA, Bauab TM, Chorilli M, Ruiz-Gaitán A.   +14 more
europepmc   +1 more source

Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study. [PDF]

Clin Pharmacol
Luo C, Jiang Y, Yan H, Sun K, Li W, Cao M, Zhu L, Hu X, Tong J, Zheng C.   +9 more
europepmc   +1 more source

Real-life multicenter experience of long-term treatment with venetoclax plus azacitidine for acute myeloid leukemia in China. [PDF]

Sci Rep
Chen X, Yan Q, Li C, Liu F, Guo S, Zhao J, Liang Y, Wang H, Li W, Yuan G.   +9 more
europepmc   +1 more source

Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan. [PDF]

Blood Neoplasia
Kanaya M, Mukai Y, Yoshimoto G, Kobayashi M, Kajikawa S, Suzuki T, Miyashita N, Harada S, Ishio T, Yokoyama E, Izumiyama K, Saito M, Morioka M, Mori A, Matsukawa T, Onozawa M, Moriyama M, Chi S, Doki K, Teshima T, Minami Y, Homma M, Kondo T.   +22 more
europepmc   +1 more source